Use of urokinase in the treatment of tuberculous meningitis hydrocephalus
Neurosciences. 2009; 14 (1): 75-77
Dans Anglais
| IMEMR
| ID: emr-92231
ABSTRACT
We present a patient with hydrocephalus after tuberculous meningitis successfully treated with urokinase. She presented with multiple episodes of headache, fever, and vomiting. She underwent external ventricular drainage and was treated with urokinase in addition to dexamethasone, acetazolamide, and 4 antituberculous drugs. She was evaluated clinically, radiologically, and by laboratory work-up. On short-term clinical follow-up [3 months], she was asymptomatic after the treatment with urokinase. She was radiologically evaluated 3 weeks after the treatment. An MRI of the brain showed a decrease in ventricular size. Urokinase can be considered as a safe and promising adjunctive treatment for tuberculous meningitis hydrocephalus
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Méningite tuberculeuse
/
Activateur du plasminogène de type urokinase
/
Résultat thérapeutique
/
Hydrocéphalie
/
Antituberculeux
Type d'étude:
Enquête cas-témoins / Études cas/témoins
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Neurosciences
Année:
2009
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS